Clinical evidence that immunogenic cell death sensitizes to PD-1/PD-L1 blockade.

Kepp O, Zitvogel L, Kroemer G.

Open source

DOI
10.1080/2162402x.2019.1637188
Published
2019-07-22
Container
Oncoimmunology
Publisher
Not recorded
Open access
no

Credibility signals

uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/2162402x.2019.1637188,
  title = {Clinical evidence that immunogenic cell death sensitizes to PD-1/PD-L1 blockade.},
  author = {Kepp O and  Zitvogel L and  Kroemer G.},
  year = {2019},
  journal = {Oncoimmunology},
  doi = {10.1080/2162402x.2019.1637188},
  url = {https://doi.org/10.1080/2162402x.2019.1637188}
}

RIS

TY  - JOUR
TI  - Clinical evidence that immunogenic cell death sensitizes to PD-1/PD-L1 blockade.
AU  - Kepp O
AU  -  Zitvogel L
AU  -  Kroemer G.
PY  - 2019
JO  - Oncoimmunology
DO  - 10.1080/2162402x.2019.1637188
UR  - https://doi.org/10.1080/2162402x.2019.1637188
ER  - 

APA

O, K., L, Z., & G., K. (2019). Clinical evidence that immunogenic cell death sensitizes to PD-1/PD-L1 blockade.. Oncoimmunology. https://doi.org/10.1080/2162402x.2019.1637188

Source records